Literature DB >> 7104492

A simple laboratory alternative to irreversibly sickled cell (ISC) counts.

M R Clark, N Mohandas, S H Embury, B H Lubin.   

Abstract

Irreversibly sickled cells (ISC) are considered to be a hallmark of sickle cell disease, yet their number in peripheral blood smears varies greatly among different homozygous SS patients. This variation has suggested a role for ISC in the varying clinical manifestations of the disease. Efforts to determine the role of ISC have been complicated by the difficulty in standardizing the quantification of these cells. For this reason, we have attempted to develop an alternative method of quantification that would be less variable than the microscopic counting of cells on blood smears. Because ISC are dehydrated dense cells, a measurement based on cell density seemed an attractive alternative approach. Analysis of whole blood samples on a simple, 2-step density gradient, spun in a microhematocrit centrifuge, showed a strong correlation between the proportion of high density cells and the percentage of morphologically identified ISC. Parallel ektacytometric measurements of cell deformability, another parameter that reflects the low water content and high MCHC of ISC, were also strongly correlated with ISC counts. These findings suggest that either of these measurements, sensitive to the special physical properties of ISC, could be used as an objective substitute for the microscopic counting of ISC.

Entities:  

Mesh:

Year:  1982        PMID: 7104492

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.

Authors:  J Stuart; P C Stone; Y Y Bilto; A J Keidan
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

2.  Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.

Authors:  S H Embury; M R Clark; G Monroy; N Mohandas
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

3.  Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.

Authors:  C T Noguchi; D A Torchia; A N Schechter
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

4.  Optical measurement of biomechanical properties of individual erythrocytes from a sickle cell patient.

Authors:  HeeSu Byun; Timothy R Hillman; John M Higgins; Monica Diez-Silva; Zhangli Peng; Ming Dao; Ramachandra R Dasari; Subra Suresh; YongKeun Park
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

5.  Rheological effects of bed rest in sickle cell disease.

Authors:  A J Keidan; J Stuart
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

6.  Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.

Authors:  E Evans; N Mohandas; A Leung
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response.

Authors:  Alina Sadaf; Charles T Quinn; Jennifer B Korpik; Amanda Pfeiffer; Mary Reynaud; Omar Niss; Punam Malik; Russell E Ware; Theodosia A Kalfa; Patrick T McGann
Journal:  Blood Cells Mol Dis       Date:  2021-05-11       Impact factor: 2.372

8.  Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.

Authors:  Minke A E Rab; Brigitte A van Oirschot; Jennifer Bos; Tesy H Merkx; Annet C W van Wesel; Osheiza Abdulmalik; Martin K Safo; Birgitta A Versluijs; Maite E Houwing; Marjon H Cnossen; Jurgen Riedl; Roger E G Schutgens; Gerard Pasterkamp; Marije Bartels; Eduard J van Beers; Richard van Wijk
Journal:  Am J Hematol       Date:  2019-03-08       Impact factor: 10.047

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.